Peter K Gregersen Selected Research

TNF Receptor-Associated Factor 1

9/2011	The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans.
2/2011	Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci.
7/2009	REL, encoding a member of the NF-kappaB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis.
9/2007	TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter K Gregersen Research Topics

Disease

65	Rheumatoid Arthritis 01/2021 - 09/2002
27	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 06/2002
22	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 09/2002
12	Arthritis (Polyarthritis) 01/2021 - 04/2003
10	Inflammation (Inflammations) 01/2019 - 09/2007
5	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021 - 08/2004
5	Neoplasms (Cancer) 01/2018 - 12/2006
4	Crohn Disease (Crohn's Disease) 09/2013 - 01/2004
4	Infections 05/2013 - 01/2004
4	IgA Deficiency 01/2012 - 04/2007
3	Endometriosis 01/2022 - 01/2018
3	Ovarian Epithelial Carcinoma 01/2018 - 10/2017
3	Dermatomyositis (Dermatopolymyositis) 01/2017 - 04/2006
3	Myasthenia Gravis 03/2016 - 11/2009
3	Disease Susceptibility (Diathesis) 04/2015 - 09/2002
3	Ulcerative Colitis 11/2009 - 01/2004
2	COVID-19 01/2022 - 01/2021
2	Osteoarthritis 12/2019 - 01/2019
2	Myositis (Idiopathic Inflammatory Myopathies) 01/2019 - 01/2017
2	Rheumatic Diseases (Rheumatism) 10/2016 - 02/2015
2	Necrosis 10/2016 - 04/2002
2	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2015 - 04/2006
2	Systemic Scleroderma (Systemic Sclerosis) 07/2011 - 11/2006
2	Genetic Predisposition to Disease (Genetic Predisposition) 09/2010 - 06/2010
2	Multiple Sclerosis 06/2010 - 11/2009
2	Nephritis 04/2009 - 05/2008
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2006 - 01/2004
1	Human Influenza (Influenza) 01/2022
1	Asymptomatic Infections 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Adenomyosis 11/2020
1	Leiomyoma (Uterine Fibroids) 11/2020
1	Uterine Hemorrhage (Uterine Bleeding) 11/2020
1	Hypersensitivity (Allergy) 01/2019
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Polymyositis 01/2017
1	Inclusion Body Myositis 01/2017
1	Genetic Risk Score 01/2016

Drug/Important Bio-Agent (IBA)

25	AutoantibodiesIBA 01/2022 - 12/2005
23	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2002
12	Anti-Citrullinated Protein AntibodiesIBA 01/2021 - 12/2005
11	CytokinesIBA 01/2022 - 04/2003
11	HLA-DRB1 Chains (HLA DRB1)IBA 01/2017 - 09/2002
11	EpitopesIBA 01/2017 - 09/2002
10	AntibodiesIBA 11/2020 - 11/2005
10	HLA Antigens (Human Leukocyte Antigens)IBA 09/2015 - 09/2002
9	cyclic citrullinated peptideIBA 01/2021 - 12/2005
6	Peptides (Polypeptides)IBA 12/2019 - 01/2012
6	Biomarkers (Surrogate Marker)IBA 10/2017 - 06/2006
6	InterferonsIBA 07/2015 - 12/2004
5	Pharmaceutical PreparationsIBA 01/2021 - 05/2013
5	Immunoglobulin A (IgA)IBA 12/2019 - 01/2010
5	RNA (Ribonucleic Acid)IBA 01/2019 - 01/2013
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 01/2009
5	Interferon Type IIBA 10/2016 - 12/2004
5	Biological ProductsIBA 10/2016 - 03/2008
5	DNA (Deoxyribonucleic Acid)IBA 11/2009 - 04/2007
4	Rheumatoid FactorIBA 01/2021 - 12/2005
4	Amino Acids FDA Link 01/2017 - 01/2012
4	EnzymesIBA 09/2013 - 04/2002
4	TNF Receptor-Associated Factor 1IBA 09/2011 - 09/2007
3	Interferon Regulatory FactorsIBA 01/2020 - 05/2006
3	ChemokinesIBA 06/2013 - 12/2006
3	AntigensIBA 05/2012 - 01/2009
3	Protein Tyrosine PhosphatasesIBA 09/2011 - 08/2004
3	NF-kappa B (NF-kB)IBA 07/2009 - 01/2004
2	Immunoglobulin G (IgG)IBA 12/2019 - 09/2013
2	HLA-DQB1 antigen (HLA DQB1)IBA 01/2019 - 01/2012
2	HLA-DQA1 antigen (HLA DQA1)IBA 01/2019 - 01/2012
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2017 - 02/2016
2	HLA-C Antigens (HLA-C)IBA 12/2015 - 01/2012
2	Phosphotransferases (Kinase)IBA 11/2015 - 09/2012
2	Vitamin D FDA LinkGeneric 07/2015 - 05/2009
2	acetyl 4-aminosalicylic acidIBA 08/2013 - 01/2009
2	Transcription Factors (Transcription Factor)IBA 05/2013 - 07/2009
2	Etanercept (Enbrel)FDA Link 03/2013 - 01/2009
2	AutoantigensIBA 11/2012 - 01/2008
2	HLA-DPB1 antigen (HLA DPB1)IBA 05/2012 - 01/2012
2	Immunoglobulin M (IgM)IBA 12/2009 - 01/2007
2	P-2 (P 2)IBA 02/2008 - 09/2007
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 04/2005 - 08/2004
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022
1	LipidsIBA 01/2021
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2021
1	Prednisolone (Predate)FDA LinkGeneric 01/2021
1	Progesterone FDA LinkGeneric 11/2020
1	Anti-Idiotypic AntibodiesIBA 12/2019
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 06/2019
1	HLA-DRB1*03:01 antigenIBA 01/2019
1	Deoxyribonucleases (DNase)FDA Link 01/2019
1	ChromatinIBA 01/2019
1	Small Cytoplasmic RNAIBA 01/2019
1	HLA-DRB1*04:01 antigenIBA 01/2019
1	histone H3 trimethyl Lys4IBA 10/2018
1	MicroRNAs (MicroRNA)IBA 10/2017
1	Tumor Necrosis Factor InhibitorsIBA 10/2016
1	Cholinergic ReceptorsIBA 03/2016
1	IgG Receptors (Fc gamma RI)IBA 02/2016

Therapy/Procedure

6	Therapeutics 02/2015 - 01/2009
2	Biological Therapy 01/2017 - 03/2013